Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine — CSCD-TCM

Atherosclerotic Heart Disease With Angina Nos Clinical Trial

Official title:
Prospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine

Status Not yet recruiting

Clinical Trial Summary

A prospective cohort study was performed in patients with angina pectoris who were treated with oral Chinese patent medicine and Western medicine.Collect primary and secondary efficacy indicators such as the incidence of cardiovascular events, using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of coronary heart disease with angina pectoris, and provide reliable data support for its clinical application.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Angina Pectoris
Atherosclerotic Heart Disease With Angina Nos
Coronary Artery Disease
Coronary Disease
Heart Diseases
Myocardial Ischemia

Clinical Trial Details

NCT number	NCT04022031
Study type	Observational
Source	Tianjin University of Traditional Chinese Medicine
Contact
Status	Not yet recruiting
Phase
Start date	September 1, 2019
Completion date	September 1, 2022

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04444024` - Effect of Hypercholesterolemia With or Without Hypertension on Coronary Artery Stenosis in Patients With Angina: a Retrospective Study
	Not yet recruiting	`NCT04026724` - Retrospective Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine